2018 annual financial data
Avalo Therapeutics 2018 Operating margin
Direct answer
Operating margin was -214.52%.
Operating income was -39,313,766 USD and net income was -40,052,810 USD.
Operating cash flow was -3,128,102 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,326,801 USD
- Operating income
- -39,313,766 USD
- Net income
- -40,052,810 USD
- Operating cash flow
- -3,128,102 USD